remitted to the U. S.  due to foreign tax credits and exclusions that may become available at the time of remittance.
At December 31, 2010, Aon had domestic federal operating loss carryforwards of $56 million that will expire at various dates from 2011 to 2024, state operating loss carryforwards of $610 million that will expire at various dates from 2011 to 2031, and foreign operating and capital loss carryforwards of $720 million and $251 million, respectively, nearly all of which are subject to indefinite carryforward.
Unrecognized Tax Provisions The following is a reconciliation of the Company’s beginning and ending amount of unrecognized tax benefits (in millions):
## Table 0 ##
As of December 31, 2010, $85 million of unrecognized tax benefits would impact the effective tax rate if recognized.
Aon does not expect the unrecognized tax positions to change significantly over the next twelve months, except for a potential reduction of unrecognized tax benefits in the range of $10-$15 million relating to anticipated audit settlements.
The Company recognizes penalties and interest related to unrecognized income tax benefits in its provision for income taxes.
Aon accrued potential penalties of less than $1 million during each of 2010, 2009 and 2008.
Aon accrued interest of less than $1 million in 2010, $2 million during 2009 and less than $1 million in 2008.
Aon has recorded a liability for penalties of $5 million and for interest of $18 million for both December 31, 2010 and 2009.
Aon and its subsidiaries file income tax returns in the U. S.  federal jurisdiction as well as various state and international jurisdictions.
Aon has substantially concluded all U. S.  federal income tax matters for years through 2006.
Material U. S.  state and local income tax jurisdiction examinations have been concluded for years through 2002.
Aon has concluded income tax examinations in its primary international jurisdictions through 2004.
repurchased under this program, and approximately 14,327,000 shares had been repurchased including preferred shares on an as-converted basis, leaving approximately 2,650,000 shares of common stock authorized for repurchase under the program.
Item 6.
Selected Financial Data
## Table 1 ##
(1) In November 2002, the Company reached an agreement in principle with the appropriate parties to resolve all current and future asbestos-related claims made against it and its affiliates in connection with the Cryovac transaction.
In connection with this settlement, the Company recorded a pre-tax charge of $850.1 million in the consolidated statement of operations in 2002, which resulted in the Company’s net loss for the year ended December 31, 2002.
The parties signed a definitive settlement agreement as of November 10, 2003 consistent with the terms of the agreement in principle.
See Note 16 to the Consolidated Financial Statements.
(2) Beginning January 1, 2002, in accordance with Statement of Financial Accounting Standards (‘‘SFAS’’) No.142, the Company stopped recording amortization expense related to goodwill.
Goodwill amortization expense was $57.0 million in 2001.
See Note 8 to the Consolidated Financial Statements.
(3) In the fourth quarter of 2004, the Company incurred restructuring and other charges of $33 million relating to global profit improvement initiatives implemented to improve the Company’s operating efficiencies and cost structure.
In 2001, the Company recorded restructuring charges of $32.8 million.
See Note 13 to the Consolidated Financial Statements.
(4) In July 2003, the Company issued $1,281.3 million of senior notes.
On July 18, 2003, the Company used the net proceeds from these offerings and additional cash on hand, approximately
Under limited circumstances, the banks and the issuers of commercial paper can end purchases of receivables interests before the above expiration dates.
A failure to comply with debt leverage or various other ratios related to our receivables collection experience could result in termination of the receivables programs.
We were in compliance with these ratios at December 31, 2015.
As of December 31, 2014, the total amount of borrowings under our U. S.  program was $36 million and there were no amounts outstanding under the European program.
Note 9 Restructuring and Relocation Activities The following table details our restructuring activities:
## Table 2 ##
Fusion On December 18, 2014, the Board of Directors of the Company approved a new restructuring plan (the “Fusion Program” or the “Plan”), which consists of a portfolio of restructuring projects across all of our divisions as part of our transformation of Sealed Air Corporation into a knowledge-based company, including reduction in headcount and consolidation and relocation of certain facilities and offices.
On July 23, 2014, we announced that we will be establishing a new global headquarters in Charlotte, North Carolina (known as our “Beacon” project).
We will relocate the headquarters for our divisions, research and development facilities, and corporate offices.
Within the next three years, we anticipate approximately 1,300 jobs will be relocated to Charlotte from our former corporate headquarters in Elmwood Park, New Jersey; and facilities in Saddle Brook, New Jersey; Racine, Wisconsin; and, Duncan and Greenville, South Carolina.
We will also relocate a small number of jobs from other locations.
The cost of the Charlotte campus is estimated to be approximately $120 million.
The Company currently estimates that it will incur aggregate costs of approximately $395 million to $405 million in connection with the implementation of this Plan.
The net cash cost of the Plan is expected to be in the range of $330 million to $340 million.
The costs associated with the Plan, the majority of which are expected to be incurred between 2015 and 2017, will primarily consist of (i) a reduction in headcount through reorganization and integration, including severance and termination benefits for employees, expected to be approximately $115 million to $120 million, and (ii) other costs associated with the Plan, primarily relating to the rationalization, consolidation and relocation of certain portions of our global supply chain and other facilities and offices, expected to be approximately $280 million to $285 million.
Included in the total cash costs, the Company anticipates approximately $190 million to $200 million of capital expenditures related to the Plan, including the building of the Charlotte campus, of which the majority is expected to continue in 2016.
The other associated costs included in the table above primarily consist of consulting and other costs incurred in connection with the project relocation efforts, which were included in selling, general and administrative expenses on the Consolidated Statements of Operations for the year ended December 31, 2015 and 2014.
The restructuring charges included in the table above primarily consist of termination and benefit costs.
On August 31, 2014, in connection with our relocation efforts, we signed an agreement for purchase and sale relating to our building located in Racine, Wisconsin.
As of December 31, 2014, the building and certain related assets met the criteria of assets held for sale classification.
Accordingly, we reclassified $26 million from property, plant and equipment to assets held for sale as of December 31, 2014.
The sale closed in January 2015.
The final sales price was $30 million, of which net proceeds of $24 million were received as part of the closing along with a $6 million unsecured promissory note which was received in the third quarter of 2015.
We recorded a pre-tax gain on the sale of approximately $3 million in January 2015.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS At December 31, 2007, future minimum rental payments required under operating leases for continuing operations that have initial or remaining noncancelable lease terms in excess of one year, net of sublease rental income, most of which pertain to real estate leases, are as follows:
## Table 3 ##
RAYMOND JAMES FINANCIAL, INC.  AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
## Table 4 ##
(1) All components of other comprehensive (loss) income are attributable to Raymond James Financial, Inc.  (2) On December 24, 2012, we acquired a 45% interest in ClariVest Asset Management, LLC, see Notes 1 and 3 for discussion.
See accompanying Notes to Consolidated Financial Statements.
Index 62 Non-interest expenses in fiscal year 2014 decreased $74 million, or 63%.
The decrease is primarily a result of a decrease in acquisition related expenses since our integration of Morgan Keegan was substantially complete as of September 30, 2013.
The acquisition related expenses incurred in fiscal year 2013 were primarily comprised of expenses associated with the integration of Morgan Keegan’s operations into our own (see Note 3 of our Notes to Consolidated Financial Statements in this Form 10-K for additional information on the components of the fiscal year 2013 expense).
The portion of revenue attributable to noncontrolling interests decreased in fiscal year 2014 by nearly $56 million compared to fiscal year 2013.
Of the fiscal year 2013 Albion revenues received, approximately $51 million related to the portion of that investment which we did not own.
Certain statistical disclosures by bank holding companies As a financial holding company, we are required to provide certain statistical disclosures by bank holding companies pursuant to the SEC’s Industry Guide 3.

<table><tr><td></td><td>2010</td><td>2009</td></tr><tr><td>Balance at January 1</td><td>$77</td><td>$86</td></tr><tr><td>Additions based on tax positions related to the current year</td><td>7</td><td>2</td></tr><tr><td>Additions for tax positions of prior years</td><td>4</td><td>5</td></tr><tr><td>Reductions for tax positions of prior years</td><td>-7</td><td>-11</td></tr><tr><td>Settlements</td><td>-1</td><td>-10</td></tr><tr><td>Lapse of statute of limitations</td><td>-5</td><td>-3</td></tr><tr><td>Acquisitions</td><td>26</td><td>6</td></tr><tr><td>Foreign currency translation</td><td>-1</td><td>2</td></tr><tr><td>Balance at December 31</td><td>$100</td><td>$77</td></tr></table>
<table><tr><td> </td><td> 2005</td><td> 2004</td><td> 2003</td><td>2002-1</td><td> 2001</td></tr><tr><td> </td><td colspan="5"> (In millions of dollars, except per share data)  </td></tr><tr><td> Consolidated Statement of Operations Data:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Net sales</td><td>$4,085.1</td><td>$3,798.1</td><td>$3,531.9</td><td>$3,204.3</td><td>$3,067.5</td></tr><tr><td>Gross profit</td><td>1,158.0</td><td>1,162.1</td><td>1,112.8</td><td>1,057.6</td><td>990.3</td></tr><tr><td>Operating profit-2(3)</td><td>510.4</td><td>503.0</td><td>540.9</td><td>517.0</td><td>387.8</td></tr><tr><td>Earnings (loss) before income taxes</td><td>376.6</td><td>322.9</td><td>376.9</td><td>-391.9</td><td>297.5</td></tr><tr><td>Net earnings (loss)</td><td>255.8</td><td>215.6</td><td>240.4</td><td>-309.1</td><td>156.7</td></tr><tr><td>Series A convertible preferred stock dividends-4</td><td>—</td><td>—</td><td>28.6</td><td>53.8</td><td>55.0</td></tr><tr><td>Earnings (loss) per common share</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Basic</td><td>$3.09</td><td>$2.56</td><td>$2.21</td><td>$-4.20</td><td>$1.30</td></tr><tr><td>Diluted</td><td>$2.69</td><td>$2.25</td><td>$1.97</td><td>$-4.30</td><td>$1.22</td></tr><tr><td>  Consolidated Balance Sheet Data:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Working capital net asset (net liability)(5)</td><td>$161.9</td><td>$307.4</td><td>$280.4</td><td>$-34.5</td><td>$149.4</td></tr><tr><td>Total assets-5</td><td>4,864.2</td><td>4,855.0</td><td>4,704.1</td><td>4,260.8</td><td>3,907.9</td></tr><tr><td>Long-term debt, less current portion-4(5)(6)</td><td>1,813.0</td><td>2,088.0</td><td>2,259.8</td><td>868.0</td><td>788.1</td></tr><tr><td>Series A convertible preferred stock-4</td><td>—</td><td>—</td><td>—</td><td>1,327.0</td><td>1,366.2</td></tr><tr><td>Total shareholders' equity</td><td>1,392.1</td><td>1,333.5</td><td>1,123.6</td><td>813.0</td><td>850.2</td></tr><tr><td>  Other Data:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>EBIT-8</td><td>$526.3</td><td>$476.6</td><td>$512.9</td><td>$-326.0</td><td>$374.3</td></tr><tr><td>Depreciation and amortization-2</td><td>174.6</td><td>179.5</td><td>173.2</td><td>165.0</td><td>220.6</td></tr><tr><td>EBITDA-7</td><td>700.9</td><td>656.1</td><td>686.1</td><td>-161.0</td><td>594.9</td></tr><tr><td>Capital expenditures</td><td>96.9</td><td>102.7</td><td>124.3</td><td>91.6</td><td>146.3</td></tr></table>
<table><tr><td></td><td colspan="11">Year Ended December 31,</td></tr><tr><td></td><td colspan="4">2015</td><td colspan="4">2014</td><td colspan="3">2013</td></tr><tr><td>(In millions)</td><td>IOP</td><td>EQIP</td><td>Fusion</td><td>Total</td><td>IOP</td><td>EQIP</td><td>Fusion</td><td>Total</td><td>IOP</td><td>EQIP</td><td>Total</td></tr><tr><td>Other associated costs</td><td>$4.6</td><td>$9.1</td><td>$29.2</td><td>$42.9</td><td>$7.7</td><td>$25.7</td><td>$2.4</td><td>$35.8</td><td>$14.1</td><td>$12.5</td><td>$26.6</td></tr><tr><td>Restructuring charges</td><td>0.6</td><td>0.1</td><td>77.6</td><td>78.3</td><td>13.2</td><td>47.0</td><td>5.5</td><td>65.7</td><td>-7.0</td><td>80.8</td><td>73.8</td></tr><tr><td>Total</td><td>$5.2</td><td>$9.2</td><td>$106.8</td><td>$121.2</td><td>$20.9</td><td>$72.7</td><td>$7.9</td><td>$101.5</td><td>$7.1</td><td>$93.3</td><td>$100.4</td></tr></table>
<table><tr><td>2008</td><td>$317</td></tr><tr><td>2009</td><td>275</td></tr><tr><td>2010</td><td>236</td></tr><tr><td>2011</td><td>214</td></tr><tr><td>2012</td><td>191</td></tr><tr><td>Later years</td><td>597</td></tr><tr><td>Total minimum payments required</td><td>$1,830</td></tr></table>
<table><tr><td></td><td colspan="3">Year ended September 30,</td><td></td></tr><tr><td></td><td>2015</td><td>2014</td><td>2013</td><td></td></tr><tr><td></td><td colspan="3">(in thousands, except per share amounts)</td><td></td></tr><tr><td>Common stock, par value $.01 per share:</td><td></td><td></td><td></td><td></td></tr><tr><td>Balance, beginning of year</td><td>$1,444</td><td>$1,429</td><td>$1,404</td><td></td></tr><tr><td>Share issuances</td><td>47</td><td>15</td><td>25</td><td></td></tr><tr><td>Balance, end of year</td><td>1,491</td><td>1,444</td><td>1,429</td><td></td></tr><tr><td>Additional paid-in capital:</td><td></td><td></td><td></td><td></td></tr><tr><td>Balance, beginning of year</td><td>1,239,046</td><td>1,136,298</td><td>1,030,288</td><td></td></tr><tr><td>Employee stock purchases</td><td>23,847</td><td>20,234</td><td>18,319</td><td></td></tr><tr><td>Exercise of stock options and vesting of restricted stock units, net of forfeitures</td><td>21,351</td><td>8,780</td><td>30,640</td><td></td></tr><tr><td>Restricted stock, stock option and restricted stock unit expense</td><td>68,196</td><td>65,410</td><td>58,689</td><td></td></tr><tr><td>Excess tax benefit (reduction of prior tax benefits) from share-based payments</td><td>-8,115</td><td>7,437</td><td>2,590</td><td></td></tr><tr><td>Purchase of additional equity interest in subsidiary</td><td>—</td><td>—</td><td>-4,531</td><td></td></tr><tr><td>Other</td><td>454</td><td>887</td><td>303</td><td></td></tr><tr><td>Balance, end of year</td><td>1,344,779</td><td>1,239,046</td><td>1,136,298</td><td></td></tr><tr><td>Retained earnings:</td><td></td><td></td><td></td><td></td></tr><tr><td>Balance, beginning of year</td><td>3,023,845</td><td>2,635,026</td><td>2,346,563</td><td></td></tr><tr><td>Net income attributable to Raymond James Financial, Inc.</td><td>502,140</td><td>480,248</td><td>367,154</td><td></td></tr><tr><td>Cash dividends declared</td><td>-106,271</td><td>-91,133</td><td>-78,208</td><td></td></tr><tr><td>Other</td><td>5</td><td>-296</td><td>-483</td><td></td></tr><tr><td>Balance, end of year</td><td>3,419,719</td><td>3,023,845</td><td>2,635,026</td><td></td></tr><tr><td>Treasury stock:</td><td></td><td></td><td></td><td></td></tr><tr><td>Balance, beginning of year</td><td>-121,211</td><td>-120,555</td><td>-118,762</td><td></td></tr><tr><td>Purchases/surrenders</td><td>-64,780</td><td>-2,173</td><td>-8,214</td><td></td></tr><tr><td>Exercise of stock options and vesting of restricted stock units, net of forfeitures</td><td>-17,464</td><td>1,517</td><td>6,421</td><td></td></tr><tr><td>Balance, end of year</td><td>-203,455</td><td>-121,211</td><td>-120,555</td><td></td></tr><tr><td>Accumulated other comprehensive loss:<sup>-1</sup></td><td></td><td></td><td></td><td></td></tr><tr><td>Balance, beginning of year</td><td>-1,888</td><td>10,726</td><td>9,447</td><td></td></tr><tr><td>Net change in unrealized losses on available for sale securities and non-credit portion of other-than-temporary impairment losses, net of tax</td><td>-3,325</td><td>6,021</td><td>15,042</td><td></td></tr><tr><td>Net change in currency translations and net investment hedges, net of tax</td><td>-30,640</td><td>-18,635</td><td>-13,763</td><td></td></tr><tr><td>Net change in cash flow hedges, net of tax</td><td>-4,650</td><td>—</td><td>—</td><td></td></tr><tr><td>Balance, end of year</td><td>-40,503</td><td>-1,888</td><td>10,726</td><td></td></tr><tr><td>Total equity attributable to Raymond James Financial, Inc.</td><td>$4,522,031</td><td>$4,141,236</td><td>$3,662,924</td><td></td></tr><tr><td>Noncontrolling interests:</td><td></td><td></td><td></td><td></td></tr><tr><td>Balance, beginning of year</td><td>$292,020</td><td>$335,413</td><td>$411,342</td><td></td></tr><tr><td>Net (loss) income attributable to noncontrolling interests</td><td>-21,462</td><td>-32,097</td><td>29,723</td><td></td></tr><tr><td>Capital contributions</td><td>19,530</td><td>22,565</td><td>30,052</td><td></td></tr><tr><td>Distributions</td><td>-23,570</td><td>-27,093</td><td>-148,871</td><td></td></tr><tr><td>Consolidation of acquired entity</td><td>—</td><td>—</td><td>7,592</td><td><sup>-2</sup></td></tr><tr><td>Derecognition resulting from acquisition of additional interests</td><td>—</td><td>—</td><td>4,126</td><td></td></tr><tr><td>Other</td><td>-2,451</td><td>-6,768</td><td>1,449</td><td></td></tr><tr><td>Balance, end of year</td><td>264,067</td><td>292,020</td><td>335,413</td><td></td></tr><tr><td>Total equity</td><td>$4,786,098</td><td>$4,433,256</td><td>$3,998,337</td><td></td></tr></table>

Question: What was the average value of the Purchases/surrenders of Treasury stock? in the years where Excess tax benefit (reduction of prior tax benefits) from share-based payments is positive? (in thousand)
Answer: -5193.5